Alexis Dormandy, Oxford Science Enterprises CEO
Oxford Science Enterprises collects $300M to offer spinouts 'scale-up capital'
For the past seven years, biotech spinouts from the University of Oxford have often tapped into a reliable source of investments from Oxford Science Enterprises, the company tasked with founding, funding and building startups based on “exceptional science” flowing out of Oxford.
And the pool has gotten $300 million (£250 million) deeper as Oxford Science Enterprises bags a new raise that puts its tally over $1 billion (£850 million).
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
